Search research articles
Contact Us
Filters
Showing results (31-40 of 77) with videos related to
Page
of 8
Sort By:
Health Economics
|
December 28, 2020
Estimating (quality-adjusted) life-year losses associated with deaths: With application to COVID-19
Andrew H Briggs, Daniel A Goldstein, Erin Kirwin, et al.
Plos One
|
October 27, 2015
Health Behavior Change after Blood Pressure Feedback
Jia Pu, Betty A Chewning, Heather M Johnson, et al.
Current Medical Research and Opinion
|
January 17, 2019
Cost-effectiveness of pembrolizumab in combination with chemotherapy versus chemotherapy and pembrolizumab monotherapy in the first-line treatment of squamous non-small-cell lung cancer in the US
Ralph P Insinga, David J Vanness, Josephine L Feliciano, et al.
Annual Review of Clinical Psychology
|
February 5, 2024
Intervention Optimization: A Paradigm Shift and Its Potential Implications for Clinical Psychology
Linda M Collins, Inbal Nahum-Shani, Kate Guastaferro, et al.
Gynecological Surgery
|
August 19, 2015
The prevalence of occult leiomyosarcoma at surgery for presumed uterine fibroids: a meta-analysis
Elizabeth A Pritts, David J Vanness, Jonathan S Berek, et al.
Skeletal Radiology
|
June 20, 2018
Diagnostic accuracy of an abbreviated MRI protocol for detecting radiographically occult hip and pelvis fractures in the elderly
Andrew B Ross, Brian Y Chan, Paul H Yi, et al.
International Journal of Women'S Health
|
August 29, 2012
Impact of estradiol-valerate/dienogest on work productivity and activities of daily living in European and Australian women with heavy menstrual bleeding
Radoslaw Wasiak, Anna Filonenko, David J Vanness, et al.
The Journal of Surgical Research
|
July 2, 2016
Outpatient air leak management after lobectomy: a CMS cost analysis
Ryan K Schmocker, David J Vanness, Ryan A Macke, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
March 19, 2003
The cost-effectiveness of acetaminophen, NSAIDs, and selective COX-2 inhibitors in the treatment of symptomatic knee osteoarthritis
Celia C Kamath, Hilal Maradit Kremers, David J Vanness, et al.
The Oncologist
|
December 25, 2019
In Reply
Kathryn E Flynn, David J Vanness, Judith M Myers, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 77) with videos related to
Sort By:
Page
of 8
Health Economics
|
December 28, 2020
Estimating (quality-adjusted) life-year losses associated with deaths: With application to COVID-19
Andrew H Briggs, Daniel A Goldstein, Erin Kirwin, et al.
Plos One
|
October 27, 2015
Health Behavior Change after Blood Pressure Feedback
Jia Pu, Betty A Chewning, Heather M Johnson, et al.
Current Medical Research and Opinion
|
January 17, 2019
Cost-effectiveness of pembrolizumab in combination with chemotherapy versus chemotherapy and pembrolizumab monotherapy in the first-line treatment of squamous non-small-cell lung cancer in the US
Ralph P Insinga, David J Vanness, Josephine L Feliciano, et al.
Annual Review of Clinical Psychology
|
February 5, 2024
Intervention Optimization: A Paradigm Shift and Its Potential Implications for Clinical Psychology
Linda M Collins, Inbal Nahum-Shani, Kate Guastaferro, et al.
Gynecological Surgery
|
August 19, 2015
The prevalence of occult leiomyosarcoma at surgery for presumed uterine fibroids: a meta-analysis
Elizabeth A Pritts, David J Vanness, Jonathan S Berek, et al.
Skeletal Radiology
|
June 20, 2018
Diagnostic accuracy of an abbreviated MRI protocol for detecting radiographically occult hip and pelvis fractures in the elderly
Andrew B Ross, Brian Y Chan, Paul H Yi, et al.
International Journal of Women'S Health
|
August 29, 2012
Impact of estradiol-valerate/dienogest on work productivity and activities of daily living in European and Australian women with heavy menstrual bleeding
Radoslaw Wasiak, Anna Filonenko, David J Vanness, et al.
The Journal of Surgical Research
|
July 2, 2016
Outpatient air leak management after lobectomy: a CMS cost analysis
Ryan K Schmocker, David J Vanness, Ryan A Macke, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
March 19, 2003
The cost-effectiveness of acetaminophen, NSAIDs, and selective COX-2 inhibitors in the treatment of symptomatic knee osteoarthritis
Celia C Kamath, Hilal Maradit Kremers, David J Vanness, et al.
The Oncologist
|
December 25, 2019
In Reply
Kathryn E Flynn, David J Vanness, Judith M Myers, et al.
Page
of 8